SCHEMBL2503237

SCHEMBL2503237

CC[C@H](c1cc(O)cc(F)c1)C(C)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR1 Q9BXC0 1/20 0.40
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA9 Q16790 1/20 0.36
HKDC1 Q2TB90 1/20 0.35
OPRM1 P35372 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
LMNA P02545 2/20 0.34
ESR1 P03372 1/20 0.34
CYP1A2 P05177 1/20 0.34
PGR P06401 1/20 0.34
CHRM2 P08172 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
AR P10275 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
CHRM1 P11229 1/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2503341 1.00 HCAR1 (0.40) HCAR1CA12CA1CA9HKDC1
SCHEMBL2495828 0.81 HCAR1 (0.35) HCAR1CA12CA1CA9FOLH1
SCHEMBL27830838 0.81 HCAR1 (0.35) HCAR1CA12CA1CA9FOLH1
SCHEMBL2503184 0.81 HCAR1 (0.35) HCAR1CA12CA1CA9FOLH1
SCHEMBL2505243 0.76 PSEN1 (0.44) LMNA
SCHEMBL2505640 0.76 PSEN1 (0.44) LMNA
SCHEMBL13731382 0.76 OPRM1 (0.57) HKDC1OPRM1CYP3A4CYP2C9CYP2C19
SCHEMBL2498460 0.76 OPRM1 (0.57) HKDC1OPRM1CYP3A4CYP2C9CYP2C19
SCHEMBL2501603 0.76 OPRM1 (0.57) HKDC1OPRM1CYP3A4CYP2C9CYP2C19
SCHEMBL13731381 0.76 OPRM1 (0.57) HKDC1OPRM1CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030354-B2 2-(5,5-Dimethylcyclopent-1-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; metabolic disorders such as type II diabetes AMGEN INC. (US) 2011-10-04 US disclosed